• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Evaluation of the effect of cinnamaldehyde per se and its interaction with ondansetron on haloperidol induced catalepsy in albino mice

    Dr. Ritesh Churihar, Dr Sapna Arun More, Dr. Pooja S. Mishra, Dr. Deepti Gupta

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 580-585

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: The aim of this study is to evaluate the per se effect of cinnamaldehyde which
is obtained from bark oil of cinnamon tree and its interaction with ondansetron on catalepsy
in Swiss albino mice.
Methods: Haloperidol induced catalepsy model was used. A group of 36 healthy mice of
either sex weighing 20-30 grams were divided at random into six groups (n=6).
Cinnamaldehyde with 98 percent purity was obtained. Catalepsy was induced by haloperidol
(1mg/kg, i.p). Control group received tween-20 20% (10ml/kg, p.o), standard groups were
administered ondansetron (0.5mg/kg and 1mg/kg, p.o ), test groups received cinnamaldehyde
in strength of 100mg/kg, and 200mg/kg and combination group of ondansetron plus
cinnamaldehyde (0.5mg/kg + 100mg/kg) per oral, respectively.
Results: In this acute study, from 60 min onwards after haloperidol administration,
ondansetron at both doses (0.5 mg/kg and 1 mg/kg), showed significantly lower cataleptic
scores as compared to all groups. Cinnamaldehyde at both strengths did not show any
significant effect as compare to control at any point of time (P>0.05). Combination of
ondansetron 0.5 mg/kg with cinnamaldehyde 100mg/kg, showed significant increase in
cataleptic score as compared to ondansetron 0.5 and 1mg/kg alone (P>0.05). Which suggest
that cinnamaldehyde abolishes the protective effect of ondansetron in haloperidol induced
catalepsy.
Keywords:
    Obliterate catalepsy Ondansetron cinnamaldehyde
  • PDF (447 K)
  • XML
(2022). Evaluation of the effect of cinnamaldehyde per se and its interaction with ondansetron on haloperidol induced catalepsy in albino mice. European Journal of Molecular & Clinical Medicine, 9(2), 580-585.
Dr. Ritesh Churihar, Dr Sapna Arun More, Dr. Pooja S. Mishra, Dr. Deepti Gupta. "Evaluation of the effect of cinnamaldehyde per se and its interaction with ondansetron on haloperidol induced catalepsy in albino mice". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 580-585.
(2022). 'Evaluation of the effect of cinnamaldehyde per se and its interaction with ondansetron on haloperidol induced catalepsy in albino mice', European Journal of Molecular & Clinical Medicine, 9(2), pp. 580-585.
Evaluation of the effect of cinnamaldehyde per se and its interaction with ondansetron on haloperidol induced catalepsy in albino mice. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 580-585.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 121
  • PDF Download: 144
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus